deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01340482

A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia

A Phase I/II, Open-Label, Repeat-Dose, Dose-Escalation Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia

Sponsor: Kyowa Kirin Co., Ltd.

Conditions X-linked Hypophosphatemia
Interventions KRN23
Updated 10 times since 2017 Last updated: Jun 14, 2024 Started: Apr 30, 2011 Primary completion: May 31, 2013 Completion: Oct 31, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on X-linked Hypophosphatemia, this trial is completed. The trial is conducted by Kyowa Kirin Co., Ltd. and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotCompleted~Aug 2019 – ~Nov 2020 · 15 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotCompleted~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Oct 2021 — Dec 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2021 — Oct 2021 [monthly]

    Completed PHASE1_PHASE2

▶ Show 5 earlier versions

  1. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  2. Aug 2019 — Nov 2020 [monthly]

    Completed PHASE1_PHASE2

  3. Jun 2018 — Aug 2019 [monthly]

    Completed PHASE1_PHASE2

  4. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kyowa Kirin Co., Ltd.
Data source: Kyowa Kirin Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations